Exton, PA, United States of America

Kensey Nash Corporation


USPTO Granted Patents = 158

% Expired Patents = 35.4



Trademarks = 2

Forward Citations = 29,460

Loading Chart...
Loading Chart...

63 inventors (with patents filed for the assignee):

goldMedal John E Nash (105 out of 166 patents)

silverMedal Douglas G Evans (59 out of 111 patents)

bronzeMedal William T Fisher (32 out of 50 patents)

4.  Kenneth R Kensey (29 out of 71 patents)

5.  David M Hoganson (13 out of 26 patents)

6.  Gregory Walters (13 out of 14 patents)

7.  Timothy Ringeisen (12 out of 27 patents)

8.  Charles W Dodson, Jr (10 out of 12 patents)

9.  Dennis M Sauro (9 out of 18 patents)

10.  John H Brekke (8 out of 22 patents)

11.  Scott M Goldman (7 out of 20 patents)

12.  Gino Bradica (7 out of 16 patents)

13.  Robert L McDade (6 out of 7 patents)

14.  Mark Eberhart (5 out of 9 patents)

15.  David Szabo (5 out of 5 patents)


Core Competencies:
Hernia Repair
Implant Materials
Drug Delivery Systems
Bioadhesive Compounds
Centrifuge
Osteosynthesis
Tissue Regeneration
Catheter Systems
Surgical Connectors
Porous Reinforcement
Biologic Liquid Separation
Wound Repair

158 patents:

Kensey Nash Corporation is a leading medical device company specializing in innovative regenerative medicine technologies. With a focus on orthopedic and neurologic surgical solutions, Kensey Nash develops and commercializes cutting-edge products that improve patient outcomes. Their products range from biomaterials and surgical devices to bioactive agents and tissue engineering technologies. Through a commitment to research, development, and collaboration, Kensey Nash continues to shape the future of regenerative medicine.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Kensey Nash Corporation
158 Patents

#2 in Exton, PA

#107 in Pennsylvania

#2,508 in US

#5,199 in the World

Exton, PA (US)
Exton, PA, United States of America
Forward Citations = 29,460

63 inventors:

Please report any incorrect information to [email protected]
Loading…